celebrities on glp 1 When Medicine Becomes Marketing: How Are Selling GLP-1s, Peptides And Longevity Through Telehealth Oprah joins wave of celebrities

GLP-1 RAs, widely prescribed for T2DM and obesity, are increasingly used by women of reproductive age

It is estimated that as many as half of diabetics have underlying NAFLD, with a higher risk of progression to NASH with fibrosis than non-diabetics

Their clinical utility, however, differs by formulation and pharmacokinetic profile

While Mounjaro has demonstrated impressive results, its not suitable for everyone

A recent Survey of Ophthalmology review synthesized findings from cardiovascular outcomes trials, retrospective database analyses, meta-analyses and preclinical studies involving semaglutide, liraglutide, dulaglutide and related agents across six ocular conditions: diabetic retinopathy (DR), glaucoma, nonarteritic anterior ischemic optic neuropathy (NAION), age-related macular degeneration (AMD), idiopathic intracranial hypertension (IIH) and dry eye disease (DED)

Yes, some GLP-1 receptor agonists, such as liraglutide and semaglutide, have been shown to reduce the risk of major cardiovascular events in people with type 2 diabetes and cardiovascular disease